[1]任秀利 柳艳萍 宋富军 王亭 倪明 张平平 刘明法.1990—2015年天津市滨海新区甲状腺癌 流行特征及长期发病趋势分析[J].国际内分泌代谢杂志,2020,40(02):73-76,80.[doi:10.3760/cma.j.issn.1673-4157.2020.02.001]
　Ren Xiuli,Liu Yanping,Song Fujun,et al.Epidemiological characteristics and long-term trends of thyroid cancer in Binhai New Area of Tianjin from 1990 to 2015[J].International Journal of Endocrinology and Metabolism,2020,40(02):73-76,80.[doi:10.3760/cma.j.issn.1673-4157.2020.02.001]
点击复制

1990—2015年天津市滨海新区甲状腺癌 流行特征及长期发病趋势分析()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
40
期数:
2020年02期
页码:
73-76,80
栏目:
论著
出版日期:
2020-03-20

文章信息/Info

Title:
Epidemiological characteristics and long-term trends of thyroid cancer in Binhai New Area of Tianjin from 1990 to 2015
作者:
任秀利 柳艳萍 宋富军 王亭 倪明 张平平 刘明法
天津市滨海新区疾病预防控制中心慢病科 300541
Author(s):
Ren Xiuli;  Liu Yanping;  Song Fujun;  Wang Ting;  Ni Ming;  Zhang Pingping;  Liu Mingfa
Department of Prevention and Control of Non-communicable Diseases, Tianjin Binhai New Area Center for Disease Control and Prevention, Tianjin 300541, China
关键词:
甲状腺癌;  发病率;  流行病学
Keywords:
Thyroid cancer;  Incidence;  Epidemiology
DOI:
10.3760/cma.j.issn.1673-4157.2020.02.001
摘要:
目的 分析1990—2015年天津市滨海新区甲状腺癌流行趋势及特征。方法 利用天津市滨海新区肿瘤监测数据,计算1990—2015年滨海新区甲状腺癌发病率、标化发病率、累积率(0～74岁)以及截缩率(35～64岁); 采用Joinpoint回归分析26年间甲状腺癌发病趋势; 采用χ2检验比较不同地区甲状腺癌发病率情况。结果 天津市滨海新区1990—2015年甲状腺癌新发病例共3 178例,粗发病率为12.36/10万,标化发病率为9.97/10万,男、女标化发病率比例为1:3.09。26年间滨海新区甲状腺癌发病率及标化发病率均呈明显上升趋势,其中以2010—2013年甲状腺癌发病率上升最为迅速[年度变化百分比(APC)=53.62%,P<0.05]; 滨海新区3个不同地区甲状腺癌发病率南高北低(χ2=115.270,P<0.001),且甲状腺癌发病增长速度南快北慢(南部地区APC=18.95%,中部地区APC=13.30%,北部地区APC=9.61%)。结论 1990—2015年滨海新区甲状腺癌发病率增长迅速,且滨海新区南部地区甲状腺癌发病率较北部地区升高。
Abstract:
Objective To analyze the epidemiological characteristics and trends of thyroid cancer in Binhai New Area of Tianjin from 1990 to 2015.Methods Data from Binhai New Area of Tianjin Cancer Register were collected. The incidence, standardized incidence, cumulative rate(0-74 years)and truncated rate(35-64 years)of thyroid cancer in Binhai New Area from 1990 to 2015 were calculated. The trends of incidence of thyroid cancer in 26 years were analyzed by Joinpoint regression. The incidences of thyroid cancer in different regions were compared by chi-square test.Results A total of 3 178 new cases of thyroid cancer were reported in Binhai New Area of Tianjin from 1990 to 2015; the average incidence was 12.36/100 000, standardized incidence was 9.97/100 000, and the ratio of male to female for standardized incidence was 1:3.09. During 26 years, the incidence and standardization incidence of thyroid cancer in Binhai New Area showed an obvious rising trend, especially from 2010 to 2013[annual percentage change(APC)=53.26%, P<0.05). In the three different regions of Binhai New Area, the incidence of thyroid cancer in the northern part of the city was significantly lower than that in the southern(χ2=115.270, P<0.001), and the growth rate of thyroid cancer incidence was fast in the south and slow in the north(southern area APC=18.95%, middle area APC=18.95%, northern area APC=18.95%).Conclusion From 1990 to 2015, the incidence of thyroid cancer increases rapidly, and the incidence of thyroid cancer in the southern area is higher than that in the northern of Binhai New Area of Tianjin.

参考文献/References:

[1] Wiltshire JJ,Drake TM,Uttley L,et al.Systematic review of trends in the incidence rates of thyroid cancer[J].Thyroid,2016,26(11):1541-1552.DOI:10.1089/thy.2016.0100.
[2] Sanabria A,Kowalski LP,Shah JP,et al.Growing incidence of thyroid carcinoma in recent years: factors underlying over diagnosis[J].Head Neck,2018,40(4):855-866.DOI:10.1002/hed.25029.
[3] 赫捷,陈万青.2016中国肿瘤登记年报[M].北京:清华大学出版社,2017:188.
[4] Bray F,Parkin DM.Evaluation of data quality in the cancer registry: principles and methods. Part Ⅰ:comparability,validity and timeliness[J].Eur J Cancer,2009,45(5):747-755.DOI:10.1016/j.ejca.2008.11.032.
[5] Parkin DM,Chen VW,Ferlay J,et al. Comparability and quality control in cancer registration [M]. IARC Technical Report No.19. Lyon:IARC,1994.
[6] Curado MP,Edwards B,Shin HR,et al. Cancer incidencein five continents [M],Vol. Ⅺ. Lyon:IARC,2008.
[7] 全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004:48-50.
[8] 董芬,张彪,单广良.中国甲状腺癌的流行现状和影响因素[J].中国癌症杂志,2016,26(1):47-52.DOI:10.3969/j.issn.1007-3969.2016.01.008.
[9] 孙嘉伟,许晓君,蔡秋茂,等.中国甲状腺癌发病趋势分析[J].中国肿瘤,2013, 22(9): 690-693.DOI:10.11735/j.issn.1004-0242.2013.09.A002.
[10] 杨雷,郑荣寿,王宁,等.2013年中国甲状腺癌发病与死亡情况[J].中华肿瘤杂志,2017,39(11):862-867.DOI:10.3760/cma.j.issn.0253-3766.2017.11.010.
[11] 郑文龙,张爽,沈成凤,等.天津市2010～2014年甲状腺癌流行特征及长期发病和死亡趋势分析[J].中国肿瘤,2018,27(9):670-674. DOI:10.11735/j.issn.1004-0242.2018.09.A006.
[12] 穆慧娟,礼彦侠,张蕊,等.辽宁省五市2000～2011年甲状腺癌发病、死亡现状及流行趋势分析[J]. 中国肿瘤,2015,24(11):889-894.DOI:10.11735/j.issn.1004-0242.2015.11.A001.
[13] 徐英,刘峥,彭绩,等.2001—2015年深圳市宝安区甲状腺癌发病趋势分析[J]. 慢性病学杂志,2018,19(2):125-128.DOI:10.16440/j.cnki.1674-8166.2018.02.004.
[14] 韩婧,康骅.甲状腺癌的发病现状及影响因素[J].实用预防医学,2018,25(7):894-897.DOI:10.3969/j.issn.1006-3110.2018.07.037.
[15] 关海霞,滕卫平,杨世明,等.不同碘摄入量地区甲状腺癌的流行病研究[J]. 中华医学杂志,2001,81(8):457-458.DOI:10.3760/j.issn.0376-2491.2001.08.004.
[16] 冯莉莉,杨琛,孙乔,等.2010—2014年上海市浦东新区甲状腺癌发病情况分析[J]. 上海预防医学,2018,30(7):574-578.DOI:10.19428/j.cnki.sjpm.2018.18581.
[17] Enewold L,Zhu K,Ron E,et al.Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980—2005[J].Cancer Epidemiol Biomarkers Prev,2009,18(3):784-791.DOI:10.1158/1055-9965.EPI-08-0960.
[18] Kilfoy BA,Devesa SS,Ward MH,et al.Gender is an age-specific effect modifier for papillary cancers of the thyroid gland[J].Cancer Epidemiol Biomarkers Prev,2009,18(4):1092-1100.DOI:10.1158/1055-9965.EPI-08-0976.
[19] 张从容,温松臣,刘华,等.沧州市水源性高碘地区病情监测分析[J].山西医药杂志,2014,43(13):1504-1505.
[20] 贾清珍,张向东.对新修订的《水源性高碘地区和高碘病区的划定》标准的解读[J].中国地方病学杂志,2017,36(3):226-229.DOI:10.3760/cma.j.issn.2095-4255.2017.03.017.

相似文献/References:

[1]于亚静 杨彩哲 关小宏 王良宸 吴石白 刘明 肖黎 张妲 刘朝阳.甲状腺癌与桥本甲状腺炎及其他相关危险因素的研究[J].国际内分泌代谢杂志,2015,(01):27.[doi:10.3760/cma.j.issn.1673-4157.2015.01.006]
　Yu Yajing*,Yang Caizhe,Guan Xiaohong,et al.Relationship between thyroid carcinoma, Hashimoto′s thyroiditis and other related risk factors[J].International Journal of Endocrinology and Metabolism,2015,(02):27.[doi:10.3760/cma.j.issn.1673-4157.2015.01.006]
[2]李兴佳 曹萌 刘超.自噬与甲状腺癌的关系[J].国际内分泌代谢杂志,2015,(01):56.[doi:10.3760/cma.j.issn.1673-4157.2015.01.014]
　Li Xingjia,Cao Meng,Liu Chao..Relationship between autophagy and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2015,(02):56.[doi:10.3760/cma.j.issn.1673-4157.2015.01.014]
[3]杨成会,缪珩.二甲双胍在甲状腺疾病治疗中的作用[J].国际内分泌代谢杂志,2015,(04):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
　Yang Chenghui,Miao Heng..Roles of metformin in the treatment of thyroid diseases[J].International Journal of Endocrinology and Metabolism,2015,(02):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
[4]孟祥慧,徐书杭,蔡可英,等.肥胖与甲状腺癌：临床新启示[J].国际内分泌代谢杂志,2014,(02):87.[doi:10.3760/cma.j.issn.1673-4157.2014.02.005]
　Meng Xianghui*,Xu Shuhang,Cai Keying,et al.Obesity and thyroid cancer: a new clinical implication[J].International Journal of Endocrinology and Metabolism,2014,(02):87.[doi:10.3760/cma.j.issn.1673-4157.2014.02.005]
[5]孙洪平,陈国芳,曹雯,等.糖尿病与甲状腺癌关系的研究进展[J].国际内分泌代谢杂志,2014,(02):90.[doi:10.3760/cma.j.issn.1673-4157.2014.02.006]
　Sun Hongping,Chen Guofang,Cao Wen,et al.Diabetes and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2014,(02):90.[doi:10.3760/cma.j.issn.1673-4157.2014.02.006]
[6]于亚静,杨彩哲,关小宏,等.桥本甲状腺炎和甲状腺癌的关系[J].国际内分泌代谢杂志,2014,(03):200.[doi:10.3760/cma.j.issn.1673-4157.2014.03.016]
　Yu Yajing,Yang Caizhe,Guan Xiaohong,et al.Relationship between Hashimoto's thyroiditis and thyroid carcinoma[J].International Journal of Endocrinology and Metabolism,2014,(02):200.[doi:10.3760/cma.j.issn.1673-4157.2014.03.016]
[7]张倍宁 闫如意 周金莲 崔彦.甲状腺癌中miRNA的表达及作用[J].国际内分泌代谢杂志,2018,38(03):167.[doi:10.3760/cma.j.issn.1673-4157.2018.03.006]
　Zhang Beining*,Yan Ruyi,Zhou Jinlian,et al.Expression and function of miRNA in thyroid carcinoma[J].International Journal of Endocrinology and Metabolism,2018,38(02):167.[doi:10.3760/cma.j.issn.1673-4157.2018.03.006]
[8]井超,王旭东.免疫治疗在甲状腺癌中的研究进展[J].国际内分泌代谢杂志,2021,41(05):459.[doi:10.3760/cma.j.cn121383-20210624-06069]
　Jing Chao,Wang Xudong..Research progress of immunotherapy in thyroid cancer[J].International Journal of Endocrinology and Metabolism,2021,41(02):459.[doi:10.3760/cma.j.cn121383-20210624-06069]
[9]何茹,徐加杰.甲状腺癌免疫微环境的研究进展[J].国际内分泌代谢杂志,2023,43(01):30.[doi:10.3760/cma.j.cn121383-20211116-11047]
　He Ru,Xu Jiajie..Advances in the study of immune microenvironment of thyroid cancer[J].International Journal of Endocrinology and Metabolism,2023,43(02):30.[doi:10.3760/cma.j.cn121383-20211116-11047]
[10]胡欣,褚晓秋,陈国芳,等.欧洲甲状腺学会/欧洲心血管介入放射学会《甲状腺癌微创治疗的临床实践指南》解读:审时与度势[J].国际内分泌代谢杂志,2023,43(03):278.[doi:10.3760/cma.j.cn121383-20211126-11069]
　Hu Xin,Chu Xiaoqiu,Chen Guofang,et al.[J].International Journal of Endocrinology and Metabolism,2023,43(02):278.[doi:10.3760/cma.j.cn121383-20211126-11069]

备注/Memo

备注/Memo:
通信作者:刘明法,Email:mingfa3385@163.com
基金项目:2017年度滨海新区卫生与计划生育科技项目(2017BWKY30)
Corresponding author: Liu Mingfa, Email:mingfa3385@163.com
Fund program:Health and Family Planning Science and Technology Project of Binhai New Area in 2017(2017BWKY30)
更新日期/Last Update: 2020-03-20